Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and renal ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

Initially the hair spray brand was a voluntarily recalled by CRLAB USA, based in California, on Dec. 12 and became a Class II ...

BLAIR COUNTY, Pa (WJAC) — The U.S. Food and Drug Administration (FDA) has issued a temporary recall of the latest Gardners ...

Black Diamond Therapeutics shows promise with BDTX-1535 for NSCLC treatment. Click here to find out why I rate BDTX stock a ...

Researchers from John Hopkins University and Stanford University built a training model using video recordings of ...

Health officials have warned against feeding pets raw food.The risk is particularly acute as bird flu spreads. Three cats who ...

Core offers FDA-approved nVNS devices with growth potential in healthcare and military markets. Click here to find out what ...

The latest recall advises that anyone who purchased Horizon's 8-ounce cartons of organic whole milk should stop drinking it ...